These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Genetic polymorphism in CD14 gene, a co-receptor of TLR4 associated with non-alcoholic fatty liver disease. Kapil S, Duseja A, Sharma BK, Singla B, Chakraborti A, Das A, Ray P, Dhiman RK, Chawla Y. World J Gastroenterol; 2016 Nov 14; 22(42):9346-9355. PubMed ID: 27895422 [Abstract] [Full Text] [Related]
3. Prevalence of Small Intestinal Bacterial Overgrowth Syndrome in Patients with Non-Alcoholic Fatty Liver Disease/Non-Alcoholic Steatohepatitis: A Cross-Sectional Study. Gkolfakis P, Tziatzios G, Leite G, Papanikolaou IS, Xirouchakis E, Panayiotides IG, Karageorgos A, Millan MJ, Mathur R, Weitsman S, Dimitriadis GD, Giamarellos-Bourboulis EJ, Pimentel M, Triantafyllou K. Microorganisms; 2023 Mar 10; 11(3):. PubMed ID: 36985296 [Abstract] [Full Text] [Related]
4. Expression of toll-like receptors 1-5 but not TLR 6-10 is elevated in livers of patients with non-alcoholic fatty liver disease. Kanuri G, Ladurner R, Skibovskaya J, Spruss A, Königsrainer A, Bischoff SC, Bergheim I. Liver Int; 2015 Feb 10; 35(2):562-8. PubMed ID: 24351080 [Abstract] [Full Text] [Related]
5. Effects of traditional chinese medicine on endotoxin and its receptors in rats with non-alcoholic steatohepatitis. Gao Y, Song LX, Jiang MN, Ge GY, Jia YJ. Inflammation; 2008 Apr 10; 31(2):121-32. PubMed ID: 18302012 [Abstract] [Full Text] [Related]
10. Increased Expression Profile and Functionality of TLR6 in Peripheral Blood Mononuclear Cells and Hepatocytes of Morbidly Obese Patients with Non-Alcoholic Fatty Liver Disease. Arias-Loste MT, Iruzubieta P, Puente Á, Ramos D, Santa Cruz C, Estébanez Á, Llerena S, Alonso-Martín C, San Segundo D, Álvarez L, López Useros A, Fábrega E, López-Hoyos M, Crespo J. Int J Mol Sci; 2016 Nov 10; 17(11):. PubMed ID: 27834919 [Abstract] [Full Text] [Related]
14. Efficacy of rifaximin on circulating endotoxins and cytokines in patients with nonalcoholic fatty liver disease. Gangarapu V, Ince AT, Baysal B, Kayar Y, Kılıç U, Gök Ö, Uysal Ö, Şenturk H. Eur J Gastroenterol Hepatol; 2015 Jul 10; 27(7):840-5. PubMed ID: 26043290 [Abstract] [Full Text] [Related]
17. The Prevalence of Small Intestinal Bacterial Overgrowth in Patients with Non-Alcoholic Liver Diseases: NAFLD, NASH, Fibrosis, Cirrhosis-A Systematic Review, Meta-Analysis and Meta-Regression. Gudan A, Jamioł-Milc D, Hawryłkowicz V, Skonieczna-Żydecka K, Stachowska E. Nutrients; 2022 Dec 09; 14(24):. PubMed ID: 36558421 [Abstract] [Full Text] [Related]
18. Role of serum toll-like receptors 2 and 4 in non-alcoholic steatohepatitis and liver fibrosis. Cengiz M, Ozenirler S, Elbeg S. J Gastroenterol Hepatol; 2015 Jul 09; 30(7):1190-6. PubMed ID: 25684563 [Abstract] [Full Text] [Related]